Loading provider…
Loading provider…
Neurology Physician in New York, NY
NPI: 1295726404Primary Practice Location
MOUNT SINAI BETH ISRAEL
281 1st Ave, New York, NY
Primary Employer
Neurology Department of Mount Sinai
mountsinai.org
HQ Phone
Get MD Susan's Phone NumberMobile
Get MD Susan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
2020
NY State Medical License
1978 - 2025

American Board of Psychiatry and Neurology
Neurology
New York Presbyterian Hospital (Columbia Campus)
Residency • Neurology
1978 - 1982
New York Presbyterian Hospital (Cornell Campus)
Internship • Internal Medicine
1977 - 1978
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
Medical School
Until 1977
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 127 | 244 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 70 | 92 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 19 | 22 |
Association of a missense change in the D2 dopamine receptor with myoclonus dystonia.
Authors: Mitchell Brin
Journal: Proc Natl Acad Sci U S A
Genetic linkage analysis in primary torsion dystonia
Authors: Bressman, S B, Fahn, S, Falk, C, Allen, F H, Suciu-Foca, N
Journal: Neurology
Diagnosis and referral delay in women with Parkinson's disease.
Authors: Rachel Saunders Pullman
Journal: Gend Med
Lead Sponsor: Northwestern University
Collaborators: Michael J. Fox Foundation for Parkinson's Research, University of Rochester, University of Iowa
Intervention / Treatment: DRUG: Placebo, DRUG: Cohort 1:Nilotinib Oral Capsules (150mg or 300mg), DRUG: Cohort 2: Nilotinib Oral Capsules (dose to be determined from Cohort 1)
Lead Sponsor: Michael J. Fox Foundation for Parkinson's Research
Collaborators: Institute for Neurodegenerative Disorders
Lead Sponsor: Parkinson's Foundation
Collaborators: Indiana University, The Parkinson Study Group, Fulgent Laboratories, Navitas Clinical Research, Inc
Intervention / Treatment: DEVICE: Lab Assay for seven genetic variants for Parkinson's Disease